Lek Pharmaceuticals d.d., Kolodvorska 27, 1234, Menges, Slovenia.
Novartis AG, Biochemiestraße 10, 6336, Langkampfen, Austria.
Drugs R D. 2022 Sep;22(3):225-234. doi: 10.1007/s40268-022-00393-4. Epub 2022 Aug 7.
The purpose of this study was to evaluate the extended physicochemical and biological stability of Sandoz Rixathon®/Riximyo® (SDZ-RTX) after exposure to out-of-fridge (OOF) conditions.
The impact of the short-term temperature excursion on stability parameters of SDZ-RTX was simulated by subsequently exposing the three batches of SDZ-RTX (100 and 500 mg) to OOF conditions, (I) 25 ± 2 °C/60 ± 5% relative humidity (RH) and (II) 30 ± 2 °C/65 ± 5% RH, for up to 21 days after more than the claimed 36-month shelf-life storage in long-term conditions (5 ± 3 °C). Analytical methods used included the cation exchange chromatography (CEX), size exclusion chromatography (SEC), and non-reducing capillary electrophoresis-sodium dodecyl sulfate (nrCE-SDS), as well as biological activity by complement-dependent cytotoxicity (CDC)-bioactivity as well as further methods, for example, related to identity and pharmacopoeia test methods.
No notable changes were observed across all batches with respect to identity (charge and primary structure), pharmaceutical tests (clarity, visible and subvisible particles analytics, container appearance, degree of coloration, pH, osmolality, extractable volume, and container closure integrity testing), protein content by UV and microbiological parameters (sterility and bacterial endotoxins) under both OOF conditions. Only minor changes were observed for parameters evaluated via SEC, CEX, and nrCE-SDS. For potency (CDC-bioactivity) only one of the batches showed a relevant change. Even for these stability-indicating test methods, all analyzed parameters complied with the shelf-life specifications.
SDZ-RTX is safe for use even under worst-case conditions, for example, after subjecting it for up to 21 days at OOF conditions (25 ± 2 °C/60 ± 5% RH or 30 ± 2 °C/65 ± 5% RH) after the batches had reached an age that was already beyond the claimed shelf-life.
本研究旨在评估 Sandoz Rixathon®/Riximyo®(SDZ-RTX)在暴露于冷藏环境之外(OOF)条件下的延长理化和生物学稳定性。
通过随后将三批 SDZ-RTX(100 和 500mg)暴露于 OOF 条件下(I)25±2°C/60±5%相对湿度(RH)和(II)30±2°C/65±5%RH,模拟短期温度偏移对 SDZ-RTX 稳定性参数的影响,这些批次在长期条件下(5±3°C)超过声称的 36 个月货架寿命后储存了超过 36 个月。使用的分析方法包括阳离子交换色谱法(CEX)、尺寸排阻色谱法(SEC)和非还原毛细管电泳-十二烷基硫酸钠法(nrCE-SDS),以及通过补体依赖性细胞毒性(CDC)-生物活性以及进一步的方法,例如与身份和药典测试方法相关的方法。
在所有批次中,身份(电荷和一级结构)、药物测试(澄清度、可见和亚可见颗粒分析、容器外观、着色程度、pH 值、渗透压、可提取物体积和容器密闭完整性测试)、通过 UV 和微生物参数(无菌和细菌内毒素)评估的蛋白质含量均未观察到明显变化在两种 OOF 条件下。仅通过 SEC、CEX 和 nrCE-SDS 评估的参数观察到较小的变化。对于效力(CDC-生物活性),只有一批次显示出相关变化。即使对于这些稳定性指示测试方法,所有分析参数均符合货架寿命规格。
即使在最坏情况下,例如在批次已经超过声称的货架寿命后,将其暴露于 OOF 条件下长达 21 天(25±2°C/60±5%RH 或 30±2°C/65±5%RH),SDZ-RTX 仍可安全使用。